Poster Abstract Session:
147. Respiratory Infections: CAP
Friday, October 5, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Adult ID, Epidemiology and Infection Control, Investigative ID, Pediatric ID

Molecular epidemiology, serotype distribution, antimicrobial sensitivity and clinical findings of adult pneumococcal pneumonia patients in Japan; hospital-based study
Satoshi Kakiuchi, M.D.; Motoi Suzuki, M.D., Ph.D.; Christopher M. Parry, M.D., Ph.D.; Michio Yasunami, M.D., Ph.D.; Konosuke Morimoto, M.D., Ph.D.
  • IDWeek Poster 2018.pdf (555.6 kB)
  • Impact of Mental Illness on Outcomes of Outpatients with Community Acquired Pneumonia
    Kari Mergenhagen, Pharm.D., BCPS AQ-ID; Megan Skelly, PharmD; Bethany Wattengel, PharmD; Randal Napierala, PharmD; John Sellick, D.O., M.S., FIDSA, FSHEA; Jennifer Schroeck, PharmD
  • CAP and Mental Illness.pdf (392.7 kB)
  • Predictive Values of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Swab PCR Assay for MRSA Pneumonia
    Man Ting Chou, PharmD; Romic Eskandarian, PharmD; Hemi Jung, PharmD; Ross Pineda, PharmD Candidate 2019; Su Lee, PharmD; Keitaro Kawaguchi, PharmD
    Non-invasive pneumococcal pneumonia in adults in Portugal: continued decline of pcv13 serotypes (2015-2017)
    Catarina Silva-Costa, PhD; Elísia Lopes, MSc; Mario Ramirez, PhD; Jose Melo-Cristino, MD, PhD
    Ninety-one Day Quality of Life Post-Pneumonia Diagnosis in Adult Patients in Japan
    Henry Glick, PhD; Taiga Miyazaki, M.D., Ph.D.; Katsuji Hirano, MD; Jose Suaya, MD, PhD; Elisa Gonzalez, MS; Bradford D. Gessner, MD; Raul E. Isturiz, MD; Adriano G. Arguedas, MD; Shigeru Kohno, MD
  • IDWeek_2018_Japan_v6f.pdf (156.6 kB)
  • Beta-hemolytic non-Group A Streptococcus pharyngitis in children.
    Holly M Frost, MD; Thomas Fritsche, MD, PhD; Matthew C. Hall, MD
    Biomarkes in Different Etiologies of Pneumonia in Pediatrics in Indonesia
    Dewi Lokida, MD, Clinical Pathologist; Nurhayati Nurhayati, MD, M.Epid; Arif Budiman, MD, Pediatrician; Helmia Farida, MD, PhD, Pediatrician; Moh Syarofil Anam, MD, MSi.Med, Pediatrician; Muhammad Rosyid Ridho, MD; Isabella Puspa Dewi, MD; Mochamad Helmi Aziz, MD, MSc; Herman Kosasih, MD, PhD; Muhammad Karyana, MD, M.Kes
    Escherichia Coli Community Acquired Pneumonia
    Teny Mathew John, MD; Abhishek Deshpande, MD, PhD; Sarah Haessler, MD; Kyle Brizendine, MD; Pei-Chun Yu, MS; Peter Imrey, PhD; Michael B Rothberg, MD, MPH
    A Single Center Quasi-Experimental Study to Evaluate the Impact of Utilizing Rapid Diagnostic Technology to Detect Methicillin-Resistant Staphylococcus aureus in Respiratory Culture Samples
    Kelsey Olson, PharmD; Sara Revolinski, PharmD, BCPS; J Njeri Wainaina, MD; Jessica Luzi, PharmD; Angela Huang, PharmD, BCPS-AQ ID
    Community-acquired Bacteremic Pneumonia in Post-Pneumococcal Vaccination Era in a Pediatric Hospital.
    Angela Gentile, MD; Julia Bakir, MD; Maria Florencia Lucion, MD; Maria Del Valle Juarez, MD; Solana Rapaport, MD; Maria Soledad Areso, MD
  • Poster 1460.pdf (805.7 kB)
  • Non-Invasive Pneumococcal Pneumonia in the United States, 2013–2014
    Almea Matanock, MD; Ryan Gierke, MPH; Nong Shang, PhD; James Watt, MD, MPH; Nisha Alden, MPH; Susan Petit, MPH; Monica M. Farley, MD, FIDSA; Lee H. Harrison, MD; Katherine Schleiss, MPH; Kari Burzlaff, MPH; Ann Thomas, MD, MPH; William Schaffner, MD, FIDSA, FSHEA; Gayle E. Langley, MD, MPH; Tamara Pilishvili, MPH, PhD
    Comparative Evaluation of Adverse Tendon Events between Recipients of Fluoroquinolones and Ceftriaxone/Azithromycin among Veterans Affairs Patients with Community Acquired Bacterial Pneumonia
    Nimish Patel, PharmD, PhD; Jeffrey Clark, PharmD; Nicholas Stornelli, Pharm.D.; Gina Belfiore, Pharm.D.; Thomas P. Lodise, PharmD, PhD
    Discovering Outpatient Stewardship Targets: An Evaluation of Community Acquired Pneumonia in the Outpatient Setting
    Bethany Wattengel, PharmD; Kari Mergenhagen, Pharm.D., BCPS AQ-ID; John Sellick, D.O., M.S., FIDSA, FSHEA; Jennifer Schroeck, PharmD; Megan Skelly, PharmD; Randal Napierala, PharmD
    Clinical Significance of Microbiologic Treatment Failure following Clinical Cure of Pneumonia.
    Owen Albin, MD; Oryan Henig, MD; Twisha S. Patel, PharmD, BCPS; Jason M. Pogue, PharmD, BCPS-AQ ID; Lindsay Petty, MD; Thomas Valley, MD; John P. Mills, MD; Keith Kaye, MD, MPH
  • IDWeekPoster100118.jpg (1.2 MB)
  • PCV13 Serotype Trends Over Time in Pneumococcal Community Acquired Pneumonia: Which Method(s) Work Best?
    Jason Leblanc, PhD; May Elsherif, MD; Lingyun Ye, MSc; Donna Mackinnon-Cameron, MMath; Ardith Ambrose, RN; Todd Hatchette, MD FRCPC; Irene Martin, BSc; Melissa K Andrew, MD, PhD; Guy Boivin, MD, MSc; William R. Bowie, MD, FRCPC, FIDSA; Karen Green, MSc, RN; Jennie Johnstone, MD, PhD; Mark Loeb, MD, MSc; Anne Mccarthy, MD, MSc; Allison McGeer, MD, MSc; Makeda Semret, MD; Sylvie Trottier, MD, PhD; Louis Valiquette, MD, MSc, FRCPC; Duncan Webster, MD; Shelly A McNeil, MD, FIDSA
    Microbial Etiology of Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults
    Abhishek Deshpande, MD, PhD; Sandra S. Richter, MD; Sarah Haessler, MD; Pei-Chun Yu, MS; Peter Imrey, PhD; Michael Rothberg, MD, MPH
    Neurocognitively-Acting Potentially Inappropriate Medications, Alcohol, and Community-Acquired Pneumonia among Patients with and without HIV
    Christopher T. Rentsch, MPH; Janet P. Tate, MPH, ScD; Kirsha S. Gordon, PhD; Alice Tseng, PharmD; Kristina M. Niehoff, PharmD; Kristina A. Crothers, MD; E. Jennifer Edelman, MD; Amy C. Justice, MD, PhD
  • IDSA_PIMS_CAP_v4.pdf (239.5 kB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.